Prediction of activity, synthesis and biological testing of anti-HSV active peptides

Chemical Biology and Drug Design

Volumn 68, Issue 1, 2006, Pages 58-66

  Jenssen, Håvard ^a   Gutteberg, Tore J ^a   Rekdal, Øystein ^b   Lejon, Tore ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Antiviral helical peptide; Heparan sulphate; Herpes simplex virus; Principal properties; Projections to latent structures; Quantitative structure activity relationships

Indexed keywords

AMINO ACID; ANTIVIRUS AGENT; HEPARAN SULFATE; POLYPEPTIDE ANTIBIOTIC AGENT;

ALPHA HELIX; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL LINE; CONCENTRATION RESPONSE; CULTURE MEDIUM; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REACTION ANALYSIS; RELIABILITY; SEQUENCE ANALYSIS; VERO CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; HERPES SIMPLEX; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SIMPLEXVIRUS; VERO CELLS;

SIMPLEXVIRUS;

EID: 33747714647     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2006.00412.x     Document Type: Article

References (18)

1. De Clercq E. (2002) Strategies in the design of antiviral drugs. Nat Rev Drug Discov;1:13-25.
2. De Clercq E. (2004) Antivirals and antiviral strategies. Nat Rev Microbiol;2:704-720.
3. Milroy D., Featherstone J. (2002) Antiviral market overview. Nat Rev Drug Discov;1:11-12.
4. Hellberg S., Sjostrom M., Skagerberg B., Wold S. (1987) Peptide quantitative structure-activity relationships, a multivariate approach. J Med Chem;30:1126-1135.
5. Wold S., Esbensen K., Geladi P. (1987) Principal component analysis. Chemometr Intell Lab Syst;2:37-52.
6. Jenssen H., Gutteberg T.J., Lejon T. (2004) Modelling of anti-HSV activity of lactoferricin analogues using amino acid descriptors. J Pept Sci;1:97-103.
7. Jenssen H., Gutteberg T.J., Lejon T. (2006) Modelling the anti-HSV activity of small, cationic peptides using amino acid descriptors. J Pept Res;66(Suppl. 1):48-56.
8. Sandberg M., Eriksson L., Jonsson J., Sjostrom M., Wold S. (1998) New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J Med Chem;41:2481-2491.
9. Jenssen H., Andersen J.H., Mantzilas D., Gutteberg T.J. (2004) A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. Antiviral Res;64:119-126.
10. Jenssen H., Andersen J.H., Uhlin-Hansen L., Gutteberg T.J., Rekdal O. (2004) Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res;61:101-109.
11. Dean H.J., Warner M.S., Terhune S.S., Johnson R.M., Spear P.G. (1995) Viral determinants of the variable sensitivity of herpes simplex virus strains to gD-mediated interference. J Virol;69:5171-5176.
12. Chou T.C., Talalay P. (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul;22:27-55.
13. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods;65:55-63.
14. Javadpour M.M., Juban M.M., Lo W.C.J., Bishop S.M., Alberty J.B., Cowell S.M., Becker C.L., McLaughlin M.L. (1996) De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem;39:3107-3113.
15. Fromm J.R., Hileman R.E., Caldwell E.E., Weiler J.M., Linhardt R.J. (1995) Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch Biochem Biophys;323:279-287.
16. Hileman R.E., Fromm J.R., Weiler J.M., Linhardt R.J. (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays;20:156-167.
17. Stenlund P., Lindberg M.J., Tibell L.A. (2002) Structural requirements for high-affinity heparin binding: alanine scanning analysis of charged residues in the C-terminal domain of human extracellular superoxide dismutase. Biochemistry;41:3168-3175.
18. Andersen H.J., Jenssen H., Sandvik K., Gutteberg T.J. (2004) The anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulfate at the cell surface. J Med Virol;74:262-271.